Pirfenidone inhalation

N/A

Report date: 2026/04/30 20:00:20

Base Information

Drug NamePirfenidone inhalation
Drug Alias NameAerodonePirfenidone Solution for InhalationAP-01
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCytokines inhibitorsCollagen inhibitorsTransforming growth factor beta inhibitors
TargetsCollagenCytokinesTransforming growth factor beta
Therapy Area/IndicationsIdiopathic Pulmonary FibrosisPulmonary FibrosisAlveolitis, Extrinsic Allergic +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumCanada +[14] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAvalyn Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesAvalyn Pharma IncAvalyn Pharma Pty Ltd
Inactive CompaniesN/A
Active IndicationsIdiopathic Pulmonary FibrosisPulmonary FibrosisAlveolitis, Extrinsic Allergic +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A